Skip to content
★ Sign in to follow
RB

Robert Benjamin Stein

Directeur Exécutif
Mimedx Group, Inc.Protagenic Therapeutics, Inc.\newAgenus Inc
Total declarations
23
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€837k

Latest filing published 17 May 2023 for Mimedx Group, INC., €57k.

Filing timeline

BuySale
Robert Benjamin Stein

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Robert Benjamin Stein: trading record in brief

This profile gathers the share dealings of Robert Benjamin Stein across 3 companies, led by Mimedx Group, Inc., Agenus Inc and Protagenic Therapeutics, Inc.\new. We count 23 filings; the first trade dates from 26 April 2016 and the latest from 16 May 2023.

Every open-market trade on record is a sale: 14 sales worth €837k. Other entries cover 7 share grants. 2023 to date brings no purchases and 7 sales.

Most recently, on 17 May 2023, the filings show an open-market sale worth €57k in Mimedx Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert Benjamin Stein

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total

23 of 23 declarations